Medical Conference: Biochemistry: NYAS: 4th Annual Meeting of the Oligonucleotide Therapeutics Society: New York, NY: Oct 15, 2008 - Oct 18, 2008

• By New York Academy of Sciences
• Published 07/8/2008
• Biochemistry
• Rating: Unrated

4th Annual Meeting of the Oligonucleotide Therapeutics Society

New York Academy of Sciences

Founded in 1817, the New York Academy of Sciences is an independent, nonprofit organization with more than 25,000 members in 140 countries.

Sign up to get personalized information from New York Academy of Sciences:
First Name:
Last Name:
Email:
Zip:
Specialty:
Select One Allergy Alternative Medicine Anesthesiology Biochemistry Cardiology Clinical Pharmacology Critical Care Dentistry Dermatology Diabetes Emergency Medicine Endocrinology Family Medicine Gastroenterology General Medicine Genetics Geriatrics Headache/Migraine Hematology Hepatology Immunology Infectious Disease Internal Medicine Medical/Business Practice Medical Ethics Multi-Speciality Physician/Practice Legal Nephrology Neurology Health Nutrition Obstetrics/Gynecology Oncology Opthalmology Orthopedics Osteopathy Otolaryngology Pathology Pain Management Pediatrics Plastic Surgery Podiatry Psychiatry Psychology Pulmonary Medicine Radiology Physician Assistants Respiratory Rheumatology Rural Medicine Sports Medicine Surgery Urology Nurse Practioner Nursing Vendor Other

View All Postings by This Contributor.

Sponsor:
The New York Academy of Sciences (NYAS) &
Oligonucleotide Therapeutics Society

Date:  Oct 15, 2008 - Oct 18, 2008

Location:
Harvard Conference Center
77 Avenue Louis Pasteur
Boston,MA 02115-0000

NYAS Faculty:
Fritz Eckstein, PhD; Max-Planck Institute for Experimental Medicine
Mike Gait, PhD; MRC Laboratory of Molecular Biology, Cambridge, UK
Mark Kay, MD, PhD; Stanford Medical School
Art Krieg, MD; Coley Pharmaceutical Group
Brett Monia, PhD; Isis Pharmaceuticals
John Rossi, PhD; Beckman Research Int. of City of Hope
Cy Stein, MD; Montefiore Hospital
Bruce Sullenger, PhD; Duke University School of Medicine
Thomas Tuschl, PhD; Rockefeller University
Kathy Granger, PhD; The New York Academy of Sciences

Call For Abstracts:
Deadline for abstract submission is Friday, August 1, 2008. For complete abstract instructions, please e-mail: OT4conf@nyas.org. Type the words "Abstract Information" in the subject line - no need to type a message. Instructions will be forwarded automatically. Any questions, please call 212.298.3725.




Link/Brochure/Contact/Join NYAS Membership

Detailed Information:
This October, leading experts in oligonucleotide research come together at Harvard Medical School, for the Fourth Annual Meeting of the Oligonucleotide Therapeutic Society. Nobel Prize-winner Phillip A. Sharp delivers the keynote lecture of this 3.5-day meeting, which features presenters from various oligonucleotide-based disciplines exploring the latest developments in their fields. Don't miss this unique meeting, an exciting opportunity to foster strong synergies between different areas of oligonucleotide research.

Spread The Word

• del.icio.us it
• Digg this
• Furl
• Reddit
• Yahoo! this!
• StumbleUpon
• Google Bookmarks
• Live Favorites
• Technorati

Comments

No Comments Found.

How would you rate the quality of this CME opportunity?
Rating: * Poor Excellent Your Name: Your Email: Your Comment: * Verification * Please copy the characters from the image above into the text field below. Doing this helps us prevent automated submissions.

This review is the subjective opinion of a CME Networks site member or user and not of CME Networks, LLC.

CMENetworks.com Comment Policy: CMEnetworks.com encourages you to add a comment to this discussion. You may not post any unlawful, threatening, libelous, defamatory, obscene or other material that would violate the law. Please note that CMEnetworks.com may edit comments for clarity or to keep out questionable or off-topic material. All comments should be relevant to the post and remain respectful of other authors or commentors. By submitting your comment, you hereby give CMEnetworks.com the right, but not the obligation, to post, air, edit, exhibit, telecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying information via all forms of media now know or hereafter devised, worldwide, in perpetuity.